Back to Search
LAUREN SIMMS, DMD
DMD
Dentist
NPI: 1477872489Individual
Specialties, Licenses & Credentials
DentistPrimary
Dentist
Code: 122300000X
22DI02434100(NJ)
Research & Publications (20)
The differential efficacy of pemetrexed according to NSCLC histology: a review of two Phase III studies.
PMID 19221167·Oncologist·2009
3-trial
Pemetrexed combined with paclitaxel: a dose-finding study evaluating three schedules in solid tumors.
PMID 18956139·Invest New Drugs·2009
3-trial
Intestinal barrier dysfunction in inflammatory bowel diseases.
PMID 18623167·Inflamm Bowel Dis·2009
6-review
Gemcitabine plus Paclitaxel versus Paclitaxel monotherapy in patients with metastatic breast cancer and prior anthracycline treatment.
PMID 18711184·J Clin Oncol·2008
3-trial
Novel NOD2 haplotype strengthens the association between TLR4 Asp299gly and Crohn's disease in an Australian population.
PMID 18213697·Inflamm Bowel Dis·2008
4-observational
Mutation of ERBB2 provides a novel alternative mechanism for the ubiquitous activation of RAS-MAPK in ovarian serous low malignant potential tumors.
PMID 19010816·Mol Cancer Res·2008
8-other
Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer.
PMID 18506025·J Clin Oncol·2008
3-trial
ATG16L1 T300A shows strong associations with disease subgroups in a large Australian IBD population: further support for significant disease heterogeneity.
PMID 18671817·Am J Gastroenterol·2008
4-observational
Bone morphogenic protein 3 inactivation is an early and frequent event in colorectal cancer development.
PMID 18311777·Genes Chromosomes Cancer·2008
8-other
The prognostic and predictive role of histology in advanced non-small cell lung cancer: a literature review.
PMID 19057275·J Thorac Oncol·2008
6-review
Reduced alpha-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn's disease.
PMID 18305068·Gut·2008
8-other
Parsing the general and specific components of depression and anxiety with bifactor modeling.
PMID 18027844·Depress Anxiety·2008
8-other
Psychometric properties of the State-Trait Inventory for Cognitive and Somatic Anxiety (STICSA): comparison to the State-Trait Anxiety Inventory (STAI).
PMID 18085930·Psychol Assess·2007
4-observational
Phase I/II pharmacokinetic study of pemetrexed and epirubicin in patients with locally advanced or metastatic breast cancer.
PMID 18269776·Clin Breast Cancer·2007
3-trial
Home care today: showcasing interdisciplinary management in home care.
PMID 17426495·Home Healthc Nurse·2007
5-case
A randomized, double-blind, phase II study of two doses of pemetrexed as first-line chemotherapy for advanced breast cancer.
PMID 17575230·Clin Cancer Res·2007
3-trial
Development and validation of the Inventory of Depression and Anxiety Symptoms (IDAS).
PMID 17845118·Psychol Assess·2007
4-observational
In search of a new, linguistically and culturally sensitive paradigm in deaf education.
PMID 18018672·Am Ann Deaf·2007
8-other
The big seven model of personality and its relevance to personality pathology.
PMID 17214592·J Pers·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 77 HAYTOWN RD
LEBANON, NJ 08833 - Phone
- (908) 894-3784
Quick Facts
- NPI
- 1477872489
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile